Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. - Wikidata - awgldk - TriplyDB

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency.

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency.

http://www.wikidata.org/entity/Q33665719

about

White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies Gene targeting, genome editing: from Dolly to editors Hematopoietic stem cell expansion and generation: the ways to make a breakthrough Engineering large animal models of human disease Livestock models for exploiting the promise of pluripotent stem cells Current progress of genetically engineered pig models for biomedical research Toward beta cell replacement for diabetes Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.Differential Mechanisms of Myocardial Conduction Slowing by Adipose Tissue-Derived Stromal Cells Derived from Different Species.The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs.Dysregulation of genome-wide gene expression and DNA methylation in abnormal cloned piglets Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment.Pig oocyte activation using a Zn²⁺ chelator, TPEN.Efficacy of the porcine species in biomedical research.Production of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined Microminipigs B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases.Production of α1,3-galactosyltransferase targeted pigs using transcription activator-like effector nuclease-mediated genome editing technology.Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.Efficient long-term cryopreservation of pluripotent stem cells at -80 °C.Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs.Partial loss of interleukin 2 receptor gamma function in pigs provides mechanistic insights for the study of human immunodeficiency syndrome.Editing the genome of hiPSC with CRISPR/Cas9: disease models.Genetically engineered livestock for biomedical models.Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.T Cell Lymphoma and Leukemia in Severe Combined Immunodeficiency Pigs following Bone Marrow Transplantation: A Case Report.Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs.Recombination activating gene-2null severe combined immunodeficient pigs and mice engraft human induced pluripotent stem cells differently.Genome editing in livestock: Are we ready for a revolution in animal breeding industry?Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.Swine models, genomic tools and services to enhance our understanding of human health and diseases.Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine.Use of gene-editing technology to introduce targeted modifications in pigs.Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs.Genome Editing of Pigs for Agriculture and Biomedicine

P2860

Q26750556-471FA253-A4A3-4814-AE71-1D7FBFBA1297 Q26768799-E3A263C3-DA99-479B-8EA8-30949D829EAA Q26771763-527108E1-B716-4D75-92E6-6747A5FFAE63 Q26785547-53B8C2D7-FA17-4EF0-91E0-23A6A493EBAE Q27011082-D23241AD-C77F-4994-B834-7BC39198FFA3 Q27027327-05B2DAD5-8E35-4065-B21C-5F31DAA01466 Q28083650-AE7A783C-4D58-4DF3-9BF1-2F7BAEADF431 Q28245450-968F0B01-679E-44F2-890E-7919814AAE4B Q28604300-B8CB0414-A250-4539-AAFA-237F0C813261 Q30396591-603AE62D-D254-4C62-8AD2-65D5CE3615DA Q33722157-29DD2871-3BE7-4ED8-B6BB-282D3753CA5B Q34043553-1E8665A9-14B4-4D0A-AFBD-5C9F795B5707 Q34304311-24FDAA42-D8D8-40A5-A8C9-BA93AC746604 Q34599892-B5FAB287-C781-4C2B-8FB2-B30A36A0B473 Q35205657-39A19C9B-E31B-4E55-8D8A-71A1F35ADBA2 Q35590331-25647D2E-080B-42A1-8C18-BEC6A63A5011 Q35667098-48EC04D0-5176-4D60-9AF1-1C88F9D622A8 Q36005768-5AFDA144-11B1-4F86-8FB4-002F01C790B5 Q36097492-4DB87755-05CB-4CF2-BD54-A7AA99613D45 Q36167875-C150AAB8-8ED3-48D8-923F-F863E659AAAB Q36661513-13BD829E-AF1A-4674-8D3A-7C6FC01E1C55 Q36723065-4E64452B-4D09-43C1-8C70-CFD16084BAC0 Q36731476-7352B03E-C72F-465B-AEB4-A8FA4F7118FB Q36841045-776D3BAC-92A3-429D-9CF0-F68C8AB1B2D7 Q37303443-5B62534C-14E3-499A-AE88-0D8F18B41E8F Q37394400-36E63479-3FBA-483F-8E51-BE3ECE53F8E4 Q37588217-C6E95AF4-242C-44B2-B123-870261AF8BD4 Q38711908-C63402DD-B710-45CB-99B9-DBA069E51FD0 Q38714822-31E91BE9-28EC-4D6F-A681-A50C25FA7273 Q38901709-FF04FE9D-416E-49D1-98EF-96835D35AA06 Q40986565-B9E20EF5-7B62-4D80-9F90-632090034B67 Q41666062-D158BF7B-9A02-489D-8C4B-48F93B28FE38 Q42378343-15E2934F-AA46-48F1-88BF-1CB8F788E1F5 Q46270371-5637B4A1-56FC-43AA-BDB0-1784F32FFAF0 Q47094378-07980971-AA44-4C7B-BB96-1E0D0A637300 Q47412922-3612BE57-BE7D-4FE2-A3C5-6BAD9EFED946 Q47563945-BFDDE40D-7566-4897-BCA3-EAA5EBC5BEFF Q49370485-7C989C06-FE1A-4062-8F07-6BD3840CF749 Q50082235-31862608-7E5C-4B12-BC57-717EFC289F8E Q58764784-DE0842C6-FB52-424A-BE40-892D591AE081

P2860

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency.

http://www.wikidata.org/entity/Q33665719

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@ast

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@en

type

label

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@ast

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@en

prefLabel

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@ast

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@en

P1433

Q33665719-8DC7361D-2417-4E1E-952E-CFFC27C3C4D8

P1476

Q33665719-BA5F258D-BCC9-433D-AAF2-A201F406BE27

P2093

Q33665719-00311DD5-BB42-4670-B910-6BDECAF28987

Q33665719-1784C0AE-002D-44A6-ADED-FEEBE928CE34

Q33665719-1897657C-A7EF-4364-9EAD-73592EC9E177

Q33665719-1A3B9594-0E75-4467-BF31-69DD34815D6D

Q33665719-1F04EA9C-963A-4FCC-9DDE-8AFA1BB2C634

Q33665719-260DB5AE-3381-442A-90AF-11272EC073B7

Q33665719-709C9167-8FE4-413E-B1E9-74CBA6516CF9

Q33665719-757209C1-0EA3-4B5D-935D-B06B3BE6CF5B

Q33665719-7B0528EB-758B-40B5-9EBA-03DB2ACF44FA

Q33665719-84E3E307-8ED1-4EB8-9AA0-189F8F8FF32D

P2860

Q33665719-09F5E1E8-4DAB-4476-BA0D-448604F511A7

Q33665719-0D61CBCE-DEE2-4E43-99C7-3091939B3B8C

Q33665719-113C3AFF-3BDE-43C4-AF37-F04959955EDE

Q33665719-29145C78-62D1-4F9A-86D6-E7375166D1CD

Q33665719-29A8C4A3-7E14-40F6-845D-55F46F1F8AD8

Q33665719-34E35882-DCEA-4D1F-B6DF-861BE0F65F88

Q33665719-3BA51EF0-50E2-450B-B532-AF72C34FF965

Q33665719-4667F63A-05E5-4E55-83F0-9CD0DE09DF88

Q33665719-469413DB-D488-4CA3-A8D6-231B0909D073

Q33665719-496F9A27-10C7-45DE-B3E6-F7D93C984D3B

P304

Q33665719-32DAE957-EB59-45EB-B300-B4F0FD72BFC6

P31

Q33665719-0A37058C-DE27-42EF-A035-F6D0EF259100

P356

Q33665719-933DD2E4-950A-4DC4-ABB0-DFA92584527E

P407

Q33665719-DD6C9C65-27B8-4F95-A671-FD2C4E4A1F5A

P433

Q33665719-F3CCF3EF-0B23-4A8C-B332-260211B9DE1F

P478

Q33665719-857373AC-3986-4FF6-A06C-B05B98B2C6ED

P577

Q33665719-25E2F6AD-C3BA-4539-AD33-558A8443CE99

P5875

Q33665719-4ECAB5D9-1D6D-44CB-9D2C-F39A782FA736

P698

Q33665719-AB3A3B3C-DBDA-4781-9BB3-7BA2BC41D31F

P932

Q33665719-6E27E0E4-23D5-4143-8D4B-1BCBAA81BB17

P356

PNAS.1406376111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Engraftment of human iPS cells ...... ere combined immunodeficiency.

@en

P2093

Aaron C Ericsson

http://www.w3.org/2001/XMLSchema#string

Alana N Brown

http://www.w3.org/2001/XMLSchema#string

Chankyu Park

http://www.w3.org/2001/XMLSchema#string

Clifton N Murphy

http://www.w3.org/2001/XMLSchema#string

Craig L Franklin

http://www.w3.org/2001/XMLSchema#string

Dae Young Kim

http://www.w3.org/2001/XMLSchema#string

Deug-Nam Kwon

http://www.w3.org/2001/XMLSchema#string

Eric M Walters

http://www.w3.org/2001/XMLSchema#string

Jae-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Hoi Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Of mice and not men: differences between mouse and human immunology

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination

A TALE nuclease architecture for efficient genome editing

Generation and characterization of severe combined immunodeficiency rats

RAG-1-deficient mice have no mature B and T lymphocytes

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases

Genomic responses in mouse models poorly mimic human inflammatory diseases

A more efficient method to generate integration-free human iPS cells

P304

7260-7265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1406376111

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262076417

http://www.w3.org/2001/XMLSchema#string

P698

24799706

http://www.w3.org/2001/XMLSchema#string

P932

4034252

http://www.w3.org/2001/XMLSchema#string